Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Cell Therapy for Retinal Degenerative Disorders: A Systematic Review and Three-Level Meta-Analysis Publisher Pubmed



Khaboushan AS1, 2 ; Ebadpour N1 ; Moghadam MMJ3 ; Rezaee Z1, 5 ; Kajbafzadeh AM1 ; Zolbin MM1
Authors

Source: Journal of Translational Medicine Published:2024


Abstract

Background: Retinal degenerative disorders (RDDs) cause vision loss by damaging retinal neurons and photoreceptors, affecting individuals of all ages. Cell-based therapy has emerged as an effective approach for the treatment of RDDs with promising results. This meta-analysis aims to comprehensively evaluate the efficacy of cell therapy in treating age-related macular degeneration (AMD), retinitis pigmentosa (RP), and Stargardt macular degeneration (SMD) as the most prevalent RDDs. Methods: PubMed, Scopus, Web of Science, and Embase were searched using keywords related to various retinal diseases and cell therapy treatments until November 25th, 2023. The studies’ quality was evaluated using the Joanna Briggs Institute’s (JBI) checklist for quasi-experimental studies. Visual acuity measured as LogMAR score was used as our main outcome. A three-level random-effect meta-analysis was used to explore the visual acuity in patients who received cell-based therapy. Heterogeneity among the included studies was evaluated using subgroup and sensitivity analyses. Moreover, meta-regression for the type of cells, year of publication, and mean age of participants were performed. Results: Overall, 8345 studies were retrieved by the search, and 39 met the eligibility criteria, out of which 18 studies with a total of 224 eyes were included in the meta-analysis. There were 12 studies conducted on AMD, 7 on SMD, and 2 on RP. Cell therapy for AMD showed significant improvement in LogMAR (p < 0.05). Also, cell therapy decreased the LogMAR score in SMD and RP (p < 0.01 and p < 0.0001, respectively). Across all conditions, no substantial publication bias was detected (p < 0.05). Conclusion: The findings of the study highlight that the application of cell therapy can enhance the visual acuity in AMD, SMD, and RP. © The Author(s) 2024.
Other Related Docs
12. Cataract Surgery in Patients With Retinitis Pigmentosa: Systematic Review, Journal of Cataract and Refractive Surgery (2023)
15. Age-Related Macular Degeneration, Atlas of Ocular Optical Coherence Tomograph# Second Edition (2023)
19. Age-Related Macular Degeneration (Armd), Diagnostics in Ocular Imaging: Cornea# Retina# Glaucoma and Orbit (2020)
20. Fetuin-A Levels in Diabetic Retinopathy: A Systematic Review and Meta-Analysis, Journal of Diabetes and Metabolic Disorders (2025)